This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- Novo Nordisk (NVO) posted a significant beat in Q3, with Ozempic sales reaching DKK 29.71 billion, surpassing estimates of DKK 27.19 billion.
- BMW (BMW) reported a sharp decline in profitability, with its automotive EBIT margin narrowing to 3.4% as the company grapples with a weak Chinese market and restructuring costs.
- Ahold Delhaize (AD) exceeded Q3 sales expectations at €23.09 billion but warned of a €200-250 million revenue hit in Q4 due to a recent cybersecurity incident.
- South Korean regulators finalized fines totaling 364 billion won for local banks over the mis-selling of Hong Kong equity-linked products, a figure significantly lower than initial estimates.
- Goldman Sachs turned more bullish on European equities, raising its 2026 STOXX 600 EPS growth forecast to 18% from 15% on the back of a recovering earnings cycle.
Pharmaceutical and Retail Giants Beat Estimates
Novo Nordisk (NVO) continues to dominate the weight-loss and diabetes market, reporting adjusted Q3 sales of DKK 79.20 billion, well ahead of the DKK 73.55 billion forecast. The results were primarily driven by the blockbuster drug Ozempic, which saw sales grow to DKK 29.71 billion. Despite the beat, the company maintained a cautious full-year outlook, projecting adjusted sales growth between -2% and +2% at constant exchange rates as it manages supply constraints.
In the retail sector, Ahold Delhaize (AD) delivered a solid third quarter with net sales of €23.09 billion, edging out the €22.99 billion estimate. While the company’s European adjusted operating margin outperformed at 4%, management flagged a significant headwind for the remainder of the year. A cybersecurity incident is expected to trim fourth-quarter sales by up to €250 million, leading the grocer to lower its 2026 earnings growth target to the low single digits.
Automotive Sector Faces Mixed Results Amid China Weakness
BMW (BMW) highlighted the ongoing struggles of European premium carmakers in China, reporting a 3.4% automotive EBIT margin, down from 5.2% a year ago. Although this figure slightly beat the 2.56% analyst consensus, the company’s overall EBIT of €1.59 billion fell short of the €1.62 billion target. BMW has intensified its structural measures, including a restructuring program, to combat falling demand and rising competition in its largest market.
Conversely, Continental (CON) provided a bright spot for the German auto industry, reporting an adjusted EBIT of €514 million, beating the €488.5 million estimate. The company’s adjusted EBIT margin reached 14.9%, significantly higher than the 13% expected by analysts. This performance was bolstered by strong pricing and cost discipline, even as global vehicle production remained under pressure.
Regulatory and Macroeconomic Outlook
In Asia, the South Korean Financial Services Commission (FSC) concluded its long-running investigation into the mis-selling of Hong Kong H-Index equity-linked securities. Seven local banks, including KB Kookmin and Shinhan, were levied a combined 364 billion won in fines. This final penalty is a substantial reduction from the 2 trillion won initially considered, reflecting the banks' efforts to compensate affected investors voluntarily.
Looking ahead, Goldman Sachs has upgraded its outlook for European corporate health. The investment bank raised its 2026 EPS growth forecast for the STOXX 600 to 18% and its 2027 forecast to 7%. Analysts cited a "secret outperformance" in sectors like banking and a cyclical recovery in the automotive industry as primary drivers for the upward revision, suggesting that the valuation gap between European and U.S. equities may begin to narrow.
Automated market updates written with AI from market data and news wire reports, published without human review.